KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
CIK 0001400482
Revenue (TTM)
$7.34M
−62.7% YoY
Q1 Apr 2017
Net Income (TTM)
−$35.97M
−3.3% YoY
Q1 Apr 2017
EPS Diluted (TTM)
−$0.96
−5.6% YoY
Q1 Apr 2017
Gross Margin
—
Q1 Apr 2017
Operating Margin
-509.7%
Q1 Apr 2017
Net Margin
-490.0%
Q1 Apr 2017
Free Cash Flow (TTM)
−$22.68M
Q1 Apr 2017
Cash
$12.24M
Q1 Apr 2017
Total Debt
—
Q1 Apr 2017
Shares Outstanding
37.94M sh
Q1 Apr 2017